215 related articles for article (PubMed ID: 8448753)
1. Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma.
Snyder HW; Mittelman A; Oral A; Messerschmidt GL; Henry DH; Korec S; Bertram JH; Guthrie TH; Ciavarella D; Wuest D
Cancer; 1993 Mar; 71(5):1882-92. PubMed ID: 8448753
[TBL] [Abstract][Full Text] [Related]
2. Treatment of patients with HIV thrombocytopenia and hemolytic uremic syndrome with protein A (Prosorba column) immunoadsorption.
Mittelman A; Bertram J; Henry DH; Snyder HW; Messerschmidt GL; Ciavarella D; Ainsworth S; Kiprov D; Arlin Z
Semin Hematol; 1989 Apr; 26(2 Suppl 1):15-8. PubMed ID: 2658095
[TBL] [Abstract][Full Text] [Related]
3. Specificity of antibody responses affected by extracorporeal immunoadsorption of plasma over columns of protein A silica.
Snyder HW; Seawell BW; Cochran SK; Balint JP; Jones FR
J Clin Apher; 1992; 7(3):110-8. PubMed ID: 1337544
[TBL] [Abstract][Full Text] [Related]
4. Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Bittencourt CE; Ha JP; Maitta RW
PLoS One; 2015; 10(5):e0127744. PubMed ID: 26000799
[TBL] [Abstract][Full Text] [Related]
5. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.
Bell WR; Braine HG; Ness PM; Kickler TS
N Engl J Med; 1991 Aug; 325(6):398-403. PubMed ID: 2062331
[TBL] [Abstract][Full Text] [Related]
6. [Microangiopathic hemolytic anemias. Clinical pattern, therapy and clinical course in 14 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome].
Krause M; Fehr J; Gmür J; Keusch G; Frick P; Oelz O
Schweiz Med Wochenschr; 1986 Nov; 116(48):1666-74. PubMed ID: 3798063
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis on thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, with plasma level of cytokine].
Wada H; Saitoh M; Tamaki S; Masuya M; Morita K; Tabata M; Tanigawa M; Kageyama S; Tsuzi K; Ohta C
Rinsho Ketsueki; 1990 Sep; 31(9):1537-43. PubMed ID: 2246829
[TBL] [Abstract][Full Text] [Related]
8. Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Lara PN; Coe TL; Zhou H; Fernando L; Holland PV; Wun T
Am J Med; 1999 Dec; 107(6):573-9. PubMed ID: 10625026
[TBL] [Abstract][Full Text] [Related]
9. A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer.
Fennelly DW; Norton L; Sznol M; Hakes TB
Cancer; 1995 Apr; 75(8):2099-102. PubMed ID: 7697600
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology and management of thrombotic microangiopathies.
Ruggenenti P; Remuzzi G
J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
[TBL] [Abstract][Full Text] [Related]
11. Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura.
Snyder HW; Cochran SK; Balint JP; Bertram JH; Mittelman A; Guthrie TH; Jones FR
Blood; 1992 May; 79(9):2237-45. PubMed ID: 1571540
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal treatment of thrombotic microangiopathy: a ten year experience.
Bueno D; Sevigny J; Kaplan AA
Ther Apher; 1999 Nov; 3(4):294-7. PubMed ID: 10608720
[TBL] [Abstract][Full Text] [Related]
13. Syndromes of Thrombotic Microangiopathy.
Shatzel JJ; Taylor JA
Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.
Myers L
Nephrol Nurs J; 2002 Apr; 29(2):171-80; quiz 181-2. PubMed ID: 11997952
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center.
Kim JW; Kim I; Oh KH; Yoon SS; Oh MD; Song YW; Heo DS; Bang YJ; Han KS; Han JS; Park S; Kim BK
Hematology; 2011 Mar; 16(2):73-9. PubMed ID: 21418736
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics and outcome of Chinese patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a 9-year retrospective study.
Zhang W; Shi H; Ren H; Shen PY; Pan XX; Li X; Chen YX; Xu YW; Chen XN; Zhu P; Chen N
Nephron Clin Pract; 2009; 112(3):c177-83. PubMed ID: 19439988
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review.
Bosch T; Wendler T
Ther Apher; 2001 Jun; 5(3):182-5. PubMed ID: 11467754
[TBL] [Abstract][Full Text] [Related]
19. Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura: outcome with plasma exchange.
Roberts AW; Gillett EA; Fleming SJ
J Clin Apher; 1991; 6(3):150-4. PubMed ID: 1787131
[TBL] [Abstract][Full Text] [Related]
20. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
Mannucci PM; Cugno M
Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
